多发性硬化症患者免疫抑制剂安全性和恶性瘤风险的最新情况
Gloria Dalla Costa1, Giancarlo Comi1,2
1Vita-Salute San Raffaele University, Milan, Italy.
Expert opinion on drug safety
|August 20, 2025
概括
高效的免疫抑制剂可以治疗多发性硬化症的复发和病变,但存在风险. 精心选择和监测患者对于平衡疾病控制与安全,尽量减少严重的不良事件至关重要.
科学领域:
- 神经学
- 免疫学
- 药理学
背景情况:
- 多发性硬化 (MS) 是一种慢性,免疫媒介的中枢神经系统疾病.
- 高效的免疫抑制剂通过减少复发和MRI病变改善了MS的治疗.
- 这些疗法也存在重大安全问题,包括感染和恶性瘤.
研究的目的:
- 审查多发性硬化症的免疫抑制疗法.
- 总结各种免疫抑制剂的疗效数据和相关风险.
- 讨论优化患者选择和监测的策略,以提高安全性.
主要方法:
- 关于多发性硬化症免疫抑制剂的最新文献.
- 对于较旧和较新的多发性硬化症治疗方法的疗效和安全性数据的摘要.
- 检查风险因素,包括血液,肝脏,自身免疫和恶性瘤风险.
主要成果:
- 较古老的药物包括阿扎西奥普林,环胺和米托克桑.
- 较新的药物包括克拉迪宾,阿勒姆图祖马布和抗CD20单克隆抗体.
- 风险包括毒性和特定恶性瘤;新药也带来需要警的风险.
结论:
- 免疫抑制剂对于活跃或耐性多发性硬化症表型至关重要.
- 必须仔细选择患者,进行查和长期监测.
- 为了平衡疾病控制与安全, 需要个性化照顾和持续的研究.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:19Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
01:20Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267